Catalyst Pharma's total assets for Q4 2024 were $851.41M, an increase of 10.28% from the previous quarter. CPRX total liabilities were $123.78M for the fiscal quarter, a 11.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.